Skip to main content
Leonard Farber, MD, Radiation Oncology, Westbury, NY

Leonard A Farber MD

Breast Cancer, Gastrointestinal Cancer, Head & Neck, Skin Cancer


Chief Executive Officer- OncoSphere Health Solutions

Join to View Full Profile
  • 695 Merrick Ave#539Westbury, NY 11590

  • Phone+1 917-514-9333

Dr. Farber is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Board-certified radiation oncologist and physician-executive entrepreneur with a demonstrated history of building, scaling, and realizing value in oncology ventures.
    Proven track record of driving growth in both private and publicly traded companies.

    Current Clinical & Strategic Roles:
    •    Founder & Chief Executive Officer, OncoSphere Health Solutions:
    •    Chief Medical Officer & Chief Clinical Officer, Cardio Health Solutions
    •    Chief Medical Officer, Integrative Molecular Solutions
    •    Chief Strategy Officer, Visionary Oncology

    Distinguished Clinical Background:

    •    Founder & Clinical Director, The Farber Center for Radiation Oncology
    •    Attending & Professor of Radiation Oncology: Held faculty positions at Memorial Sloan Kettering Cancer Center, City of Hope, and UCLA.
    •    Former Chairman, Department of Radiation Oncology, Staten Island University Hospital (North Shore/LIJ Health System).
    •    Past roles include Chief Clinical & Medical Affairs Officer and Chairman of the Scientific Advisory Board at Nanobiotix S.A., Senior Clinical Advisor, PreludeDx, and Senior Medical Director & Section Chief of Radiation Oncology, Care to Care.

    Background as an Operating Partner for Vivaris Capital’s Vican Fund provides him with an investor's perspective on Board and advisory roles- The Global Pain Foundation, Genomic Health, Adgero Biopharmaceuticals, Medtronic, BetaGlue Therapeutics SpA.
    Education & Credentials:
    Board-certified in Radiation Oncology; Residency at the Hospital of the University of Pennsylvania (Chief Resident); MD from Mount Sinai School of Medicine.
    Extracurricular Activities
    Currently a member of the board of directors of the US Olympic Committee for Bobsled and Skeleton, member of Fraternal Order of Police Surgeons Lodge, Chief Surgeon of the NY State Trooper Police PBA, and member of F. & A.M. Munn Lodge.

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemChief Residency, Radiation Oncology, 1997 - 1998
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Radiation Oncology, 1995 - 1997
  • Icahn School of Medicine at Mount Sinai/Beth Israel
    Icahn School of Medicine at Mount Sinai/Beth IsraelInternship, Internal Medicine, 1994 - 1995
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiClass of 1994, MD
  • State University of New York
    State University of New YorkBS/BA, 1990

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2017 - 2027
  • NY State Medical License
    NY State Medical License 1998 - 2027
  • LA State Medical License
    LA State Medical License 2021 - 2023
  • MI State Medical License
    MI State Medical License 2020 - 2023
  • NJ State Medical License
    NJ State Medical License 2010 - 2019
  • PA State Medical License
    PA State Medical License 1996 - 2016
  • CT State Medical License
    CT State Medical License 2009 - 2013
  • Radiation Oncology
    American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification MOSAIQ, Elekta - IMPAC Medical Systems, Inc., 2012, 2014
  • Best Doctors Best Doctors, 2012
  • Super Doctors Super Doctors, 2012

Publications & Presentations

PubMed

Journal Articles

  • Comparison of Conventional Versus Conformal External Bean Irradiation of a Stented Coronary Artery Utilizing a New Fluoroscopic Imaging Detector System.  
    Farber LA, Bloch P, York ED, Stevens CW, Herrmann H, Ruffer J, Cardiovascular Radiation Medicine 1(1): 1999;80-85
  • Detection of Recurrent Head and Neck Squamous Cell Carcinomas after Radiation Therapy with 218-F-Fluoro-2deoxy-D-glucose Positron Emission Tomography.  
    Farber LA, Bernard F, Machtay M, Alavi A, Smith RJ, Weber RS, Weinstein GS, Rosenthal DI, Laryngoscope 109: 1999;970-975
  • Dual Time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the ...  
    Hustinx R, Smith RJ, Bernard F, Rosenthal DI, Machtay M, Farber LA, Alavi A, European Journal of Nuclear Medicine, 26: 1999;1345-1348

Books/Book Chapters

Abstracts/Posters

  • Dynamic Contrast Enhanced MRI Of The Prostate Utilizing New Computer Software – An Initial Experience.
    Berkovich GY, Waldbaum R, Steckel J, Farber LA, Badillo F, Nochomowitz L, American Urological Association New York Section 104th Annual Meeting, New Delhi, India
  • Feasibility of Conformal External Beam Irradiation of Stented Coronary Artery.
    Bloch P, Farber LA, York ED, Ruffer JE, Herrmann H, Proceedings of the Scripps Clinic & Research Foundation- Second Annual Symposium on Radiotherapy...
  • The Use of Conformal External Beam Irradiation to Prevent or Reduce Restenosis in a Stented Coronary Artery Following Percutaneous Coronary Angioplasty.
    Farber LA, Bloch P, York ED, Stevens CW, Herrmann H, Ruffer JE, Advances in Cardiovascular Radiation Therapy Syllabus

Lectures

  • Rhabdomyosarcoma of the Nasopharynx. 
    Childrens Hospital of Pennsylvania Cancer Center
  • History of Radiotherapy and Review of Intravascular Radiotherapy. 
    6th Annual International Interventional Cardiology Fellows Course, San Jose, CA
  • The Management of Pediatrics Medulloblastomas. 
    Hospital of the University of Pennsylvania Cancer Center

Other

  • Utilization of a diagnostic related group (DRG) computer system to analyze the frequency of thromboembolic complications in solid tumor malignancies. 
    Farber LA, DiGiovanni G, Bruckner HW, OncoLink
    http://www.oncolink.upenn.edu

Press Mentions

  • NANOBIOTIX Announces Recommended Phase 2 Dose for NBTXR3 in Pancreatic Cancer
    NANOBIOTIX Announces Recommended Phase 2 Dose for NBTXR3 in Pancreatic CancerNovember 14th, 2022
  • NANOBIOTIX Announces First Patient Injected in New Phase 1/2 Study Evaluating Radiotherapy-Activated NBTXR3 plus Anti-PD-1 for Patients with Advanced Cancers
    NANOBIOTIX Announces First Patient Injected in New Phase 1/2 Study Evaluating Radiotherapy-Activated NBTXR3 plus Anti-PD-1 for Patients with Advanced CancersJuly 20th, 2023

Other Languages

  • Spanish, Chinese (Mandarin), Russian, Chinese (Cantonese)

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: